Biomarker Testing and Treatment Approach in NSCLC

 

Moffitt Cancer Center
A

ASCO 2021 Updates from the PACIFIC Trial: Five-Year Survival Outcomes with Durvalumab After CRT in Unresectable Stage III NSCLC

By Moffitt Cancer Center FEATURING Alberto Chiappori
By Moffitt Cancer Center FEATURING Alberto Chiappori
247 views
November 11, 2021
0 Comments
Login to view comments. Click here to Login
Biomarker Testing and Treatment Approach in NSCLC
11:46
Moffitt Cancer Center

ASCO 2021 Updates from the PACIFIC Trial: Five-Year Survival Outcome…

Feat. A. Chiappori
16:21
City of Hope

Prevalence of EGFR Mutation Testing in Early Stage Lung Cancer: Impl…

Feat. E. Massarelli
19:41
Masonic Cancer Center

EGFRm NSCLC: Resistance Mechanisms, Role of DARPP-32 in Tumor Growth

Feat. L. Hoeppner
15:47
Association of Community Cancer Centers (ACCC)

Advanced NSCLC: Receiving the Reports & Treatment Decisions

Feat. C. Presley
09:12
Jonathan Goldman

Targeted Adjuvant Therapy for Lung Cancer: The ADAURA Trial

60:29
Total Health

Virtual Evolution on NSCLC: Case Panel Discussion on Surgical Consid…

Feat. S. Kazmi, M. Das, E. Gillaspie, K. Keane
12:44
Penn Medicine Abramson Cancer Center

Advances in Adjuvant Therapy in NSCLC

Feat. C. Ciunci
08:22
Keck School of Medicine of USC Advancing Knowledge in Multidisciplinary Lung Cancer Care

Molecular Drivers in Lung Cancer: Overview of EGFR Targeted Therapy …

Feat. J. Nieva
11:38
Natasha Leighl

WCLC 2021: Incorporating ctDNA Into the Management of Advanced NSCLC…

42:57
Keck School of Medicine of USC Advancing Knowledge in Multidisciplinary Lung Cancer Care

[private by partner request] Updates on Early Stage Lung Cancer: Cha…

Feat. L. Backhus
24:02
Keck School of Medicine of USC Advancing Knowledge in Multidisciplinary Lung Cancer Care

Curative Intent Surgical Management of Advanced Primary Lung Cancer

Feat. S. Atay
15:51
Debora Bruno

ASCO 2021 Update on Racial Disparities in Biomarker Testing and Clin…